1/12
04:05 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
1/10
05:43 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
1/9
05:03 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
Low
Report
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
1/6
07:22 am
lbrx
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture [Yahoo! Finance]
Low
Report
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture [Yahoo! Finance]
1/6
07:00 am
lbrx
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
Low
Report
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
12/17
04:35 pm
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
LB Pharmaceuticals (NASDAQ:LBRX) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
04:20 pm
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
LB Pharmaceuticals (NASDAQ:LBRX) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
08:44 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) had its price target raised by analysts at Stifel Nicolaus from $27.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
LB Pharmaceuticals (NASDAQ:LBRX) had its price target raised by analysts at Stifel Nicolaus from $27.00 to $35.00. They now have a "buy" rating on the stock.
12/10
06:01 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
12/10
05:04 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
12/9
07:04 pm
lbrx
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices [Yahoo! Finance]
Low
Report
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices [Yahoo! Finance]
12/9
08:00 am
lbrx
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
Low
Report
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
12/5
04:23 pm
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
High
Report
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
11/24
08:00 am
lbrx
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
Medium
Report
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
11/12
04:53 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/12
04:15 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
11/12
08:48 am
lbrx
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer [Yahoo! Finance]
Medium
Report
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer [Yahoo! Finance]
11/12
08:00 am
lbrx
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
Medium
Report
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
11/6
04:05 pm
lbrx
LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference
Low
Report
LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference
11/6
08:00 am
lbrx
LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates
Medium
Report
LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates